Hint mode is switched on Switch off

Bicara Therapeutics, ordinary share
BCAX, US0554771032

Add a stock to WL
Choose all Reset all
Bicara Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Bicara Therapeutics Inc. operates as a biotech company. The Company focuses on treating cancer head-on by combining the precision of targeted therapies with the power of tumor microenvironment modulators to create better medicines for patients. Bicara ...
Bicara Therapeutics Inc. operates as a biotech company. The Company focuses on treating cancer head-on by combining the precision of targeted therapies with the power of tumor microenvironment modulators to create better medicines for patients. Bicara Therapeutics serves Worldwide.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Bicara Therapeutics Inc
  • Industry
    Medical Services

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BCAX
  • Placement
    13.09.2024
  • Lock up period
    180
  • Number of papers
    17,500,000
  • Volume of raised funds
    315 mln USD
  • Placement share
    33.81%
  • Final placement price
    18 USD
  • Price change since placement date
    46.75%
  • By capitalization
    931.7 mln USD
Other placements of the issuer
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    BCAX
  • Placement
    26.02.2026
  • Lock up period
    180
  • Number of papers
    7,175,000
  • Volume of raised funds
    114.8 mln USD
  • Placement share
    11.61%
  • Final placement price
    16 USD
  • Price change since placement date
    65.09%
  • By capitalization
    988.6 mln USD

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
III q eng
IV q eng
2024
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

23/07/2026 Bicara Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers;, Regulation Fd Disclosure, Financial Statements And Exhibits
24/02/2026 Bicara Therapeutics: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Financial Statements And Exhibits
12/01/2026 Bicara Therapeutics: Other Events, Financial Statements And Exhibits
06/12/2025 Bicara Therapeutics: Regulation Fd Disclosure, – Other Events, Financial Statements And Exhibits
09/06/2025 Bicara Therapeutics: Submission Of Matters To A Vote Of Security Holders
All organization news

Holders

Industry Leaders

Registration is required to get access.